In-vitro characterization of microencapsulated microtissue viability
With the rising occurrence and frequency of Type 1 Diabetes Mellitus (T1DM) together with its complications, T1DM poses a burden on paediatric patients and their families. Although islet transplantation is an alternative treatment of T1DM without the excessive need of exogenous insulin therapy wh...
Saved in:
Main Author: | |
---|---|
Other Authors: | |
Format: | Final Year Project |
Language: | English |
Published: |
Nanyang Technological University
2023
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/166801 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Summary: | With the rising occurrence and frequency of Type 1 Diabetes Mellitus (T1DM) together with
its complications, T1DM poses a burden on paediatric patients and their families. Although
islet transplantation is an alternative treatment of T1DM without the excessive need of
exogenous insulin therapy which is the typical method of treatment, it still has its restrictions
such as the lack of donors due to the need of adequate dose of islets, long term
immunosuppressive therapy and insulin resistance.
The transplantation of immuno-isolated islets is a potential approach to treat T1DM as it
enables the transplanted islets to produce insulin to restore normoglycemia without the need of
immunosuppression. However, the encapsulated islets experience inadequate oxygen delivery
as there is a lack of vasculature at the transplant location resulting in hypoxia and the death of
tissues at the islet core which results in the eventual loss of insulin independence in the long
term. Previously, unencapsulated toroid microtissues have exhibited enhanced cellular viability
and metabolic activity compared to unencapsulated spheroid microtissues probably due to
increased surface-to-volume ratio of toroidal geometry. However, the viability of microtissues
encapsulated in microcapsules remains unexplored before.
In this study, the viability of encapsulated microtissues were quantitatively evaluated using
trypan blue exclusion assay following exposure of microtissue-encapsulating microcapsules to
Ethylenediaminetetraacetic acid (EDTA) solution. We demonstrated that the retrieved number
of cells per microtissue after exposure to EDTA solution for 0.5 minute was higher than that
after EDTA treatment for 1 and 2 minutes. Furthermore, encapsulated toroid microtissues
exhibited higher average cellular viability than encapsulated spheroid microtissues in a
microcapsule system. Future study on characterizing viability of toroid and spheroid
microtissues using non-proliferative primary cell source after prolonged period of culture could
be useful in investigating the effect of microtissue geometry on cellular viability in a long-term. |
---|